Cargando…
Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders
Introduction: People with serious mental illness (SMI) use cannabis more than any other illicit drug. Cannabis use is associated with increased psychotic symptoms and is highly comorbid with alcohol use disorders (AUDs). Despite the national trend toward decriminalization, little is known about the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569619/ https://www.ncbi.nlm.nih.gov/pubmed/28861513 http://dx.doi.org/10.1089/can.2017.0006 |
_version_ | 1783259028929904640 |
---|---|
author | Skalisky, Jordan Leickly, Emily Oluwoye, Oladunni McPherson, Sterling M. Srebnik, Debra Roll, John M. Ries, Richard K. McDonell, Michael G. |
author_facet | Skalisky, Jordan Leickly, Emily Oluwoye, Oladunni McPherson, Sterling M. Srebnik, Debra Roll, John M. Ries, Richard K. McDonell, Michael G. |
author_sort | Skalisky, Jordan |
collection | PubMed |
description | Introduction: People with serious mental illness (SMI) use cannabis more than any other illicit drug. Cannabis use is associated with increased psychotic symptoms and is highly comorbid with alcohol use disorders (AUDs). Despite the national trend toward decriminalization, little is known about the prevalence, correlates, and impact of cannabis use on those with SMI receiving treatment for substance use disorders, a group at high risk for the negative effects of cannabis use. Methods: In this secondary data analysis, cannabis use prevalence, correlates, and impact on treatment outcomes were examined in 121 adults with cooccurring SMI and AUDs receiving outpatient addiction treatment in a randomized trial of contingency management (CM) for alcohol. Prevalence and frequency of cannabis use were calculated across the 7-month study period using self-report and urine tests. Cannabis users were compared with nonusers by SMI diagnosis, psychiatric symptoms, medical problems, legal problems, and HIV-risk behavior. The relationship between cannabis use and longest duration of alcohol abstinence in participants randomized to CM (n=40) was assessed. Results: Fifty-seven (47%) of participants submitted at least one cannabis-positive urine sample during the study. Out of the 2834 total samples submitted, 751 (27%) were positive for cannabis. Cannabis users were 2.2 times more likely to submit an alcohol-positive sample, and 2.5 times more likely to submit a cocaine-positive sample at baseline, relative to noncannabis users (p=0.01). Cannabis users were more likely to engage in risky sexual behavior (p=0.01) and to report being homeless (p=0.03) than nonusers. When controlling for pretreatment alcohol use, the relationship between comorbid cannabis use and alcohol abstinence during CM was not significant (p=0.77). Conclusion: Rates of comorbid cannabis use were high in this sample of adults with SMI and AUDs. Cannabis use was correlated with recent alcohol and cocaine use, risky sexual behavior, and homelessness, but not with alcohol abstinence during CM. |
format | Online Article Text |
id | pubmed-5569619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Mary Ann Liebert, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-55696192017-08-31 Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders Skalisky, Jordan Leickly, Emily Oluwoye, Oladunni McPherson, Sterling M. Srebnik, Debra Roll, John M. Ries, Richard K. McDonell, Michael G. Cannabis Cannabinoid Res Original Research Introduction: People with serious mental illness (SMI) use cannabis more than any other illicit drug. Cannabis use is associated with increased psychotic symptoms and is highly comorbid with alcohol use disorders (AUDs). Despite the national trend toward decriminalization, little is known about the prevalence, correlates, and impact of cannabis use on those with SMI receiving treatment for substance use disorders, a group at high risk for the negative effects of cannabis use. Methods: In this secondary data analysis, cannabis use prevalence, correlates, and impact on treatment outcomes were examined in 121 adults with cooccurring SMI and AUDs receiving outpatient addiction treatment in a randomized trial of contingency management (CM) for alcohol. Prevalence and frequency of cannabis use were calculated across the 7-month study period using self-report and urine tests. Cannabis users were compared with nonusers by SMI diagnosis, psychiatric symptoms, medical problems, legal problems, and HIV-risk behavior. The relationship between cannabis use and longest duration of alcohol abstinence in participants randomized to CM (n=40) was assessed. Results: Fifty-seven (47%) of participants submitted at least one cannabis-positive urine sample during the study. Out of the 2834 total samples submitted, 751 (27%) were positive for cannabis. Cannabis users were 2.2 times more likely to submit an alcohol-positive sample, and 2.5 times more likely to submit a cocaine-positive sample at baseline, relative to noncannabis users (p=0.01). Cannabis users were more likely to engage in risky sexual behavior (p=0.01) and to report being homeless (p=0.03) than nonusers. When controlling for pretreatment alcohol use, the relationship between comorbid cannabis use and alcohol abstinence during CM was not significant (p=0.77). Conclusion: Rates of comorbid cannabis use were high in this sample of adults with SMI and AUDs. Cannabis use was correlated with recent alcohol and cocaine use, risky sexual behavior, and homelessness, but not with alcohol abstinence during CM. Mary Ann Liebert, Inc. 2017-06-01 /pmc/articles/PMC5569619/ /pubmed/28861513 http://dx.doi.org/10.1089/can.2017.0006 Text en © Jordan Skalisky et al. 2017; Published by Mary Ann Liebert, Inc. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Skalisky, Jordan Leickly, Emily Oluwoye, Oladunni McPherson, Sterling M. Srebnik, Debra Roll, John M. Ries, Richard K. McDonell, Michael G. Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders |
title | Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders |
title_full | Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders |
title_fullStr | Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders |
title_full_unstemmed | Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders |
title_short | Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders |
title_sort | prevalence and correlates of cannabis use in outpatients with serious mental illness receiving treatment for alcohol use disorders |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569619/ https://www.ncbi.nlm.nih.gov/pubmed/28861513 http://dx.doi.org/10.1089/can.2017.0006 |
work_keys_str_mv | AT skaliskyjordan prevalenceandcorrelatesofcannabisuseinoutpatientswithseriousmentalillnessreceivingtreatmentforalcoholusedisorders AT leicklyemily prevalenceandcorrelatesofcannabisuseinoutpatientswithseriousmentalillnessreceivingtreatmentforalcoholusedisorders AT oluwoyeoladunni prevalenceandcorrelatesofcannabisuseinoutpatientswithseriousmentalillnessreceivingtreatmentforalcoholusedisorders AT mcphersonsterlingm prevalenceandcorrelatesofcannabisuseinoutpatientswithseriousmentalillnessreceivingtreatmentforalcoholusedisorders AT srebnikdebra prevalenceandcorrelatesofcannabisuseinoutpatientswithseriousmentalillnessreceivingtreatmentforalcoholusedisorders AT rolljohnm prevalenceandcorrelatesofcannabisuseinoutpatientswithseriousmentalillnessreceivingtreatmentforalcoholusedisorders AT riesrichardk prevalenceandcorrelatesofcannabisuseinoutpatientswithseriousmentalillnessreceivingtreatmentforalcoholusedisorders AT mcdonellmichaelg prevalenceandcorrelatesofcannabisuseinoutpatientswithseriousmentalillnessreceivingtreatmentforalcoholusedisorders |